• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Device Evaluation (ODE) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 20128583
Nov 20128582
Dec 20128583
Jan 20138583
Feb 20138584
Mar 20138589
Apr 20138588
May 20138588
Jun 20138585
Jul 20138586
Aug 20138589
Sep 20138586

FY 2013 Overall: 86%

Number of ODE intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A670
Nov 2012N/A641
Dec 2012N/A601
Jan 2013N/A646
Feb 2013N/A608
Mar 2013N/A689
Apr 2013N/A767
May 2013N/A748
Jun 2013N/A721
Jul 2013N/A791
Aug 2013N/A758
Sep 2013N/A712

FY 2013 Total: 8,384

Total number of ODE intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A809
Nov 2012N/A779
Dec 2012N/A721
Jan 2013N/A779
Feb 2013N/A721
Mar 2013N/A774
Apr 2013N/A872
May 2013N/A850
Jun 2013N/A847
Jul 2013N/A920
Aug 2013N/A854
Sep 2013N/A824

FY 2013 Total: 9,784

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.